The big shareholder groups in Compass Therapeutics, Inc. (NASDAQ:CMPX) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a ...
Real estate technology company Compass (NYSE:COMP) reported Q3 CY2025 results , with sales up 23.6% year on year to $1.85 billion. The company expects next quarter’s revenue to be around $1.64 billion ...